Refine by
Medical Data Articles & Analysis
50 news found
The launch of Caresyntax CDaaS follows the recently announced addition of CQInsights (CQI) and appointment of Dr. Bruce Ramshaw as Chief Medical Informatics Officer (CMIO) for Caresyntax. The integration of the CQI solution into the Caresyntax platform enables a stack of technologies and capabilities with new digital workflows that can acquire curated data and ...
Dr. Ali Tinazli's post at the Forbes magazine about "History Of Health Technologies And Meaningful Change In The Era Of Health 4.0" The medicine in ancient Egypt is some of the oldest in history. Although rudimentary, it was already highly personalized and with exclusive access. During the Renaissance—one of the most remarkable ages of humankind—medicine ...
While medical AI has many potential benefits, there are challenges that have not been tackled yet. One of the major challenges is the limited generalizability of many AI algorithms. Applying a medical AI algorithm that is trained in hospital A may give unexpected results when applied in hospital B. Why does this happen? Certain parameters are different between hospitals. If hospital A has Siemens ...
Anonymized medical data sharing is necessary for the advancement of medicine, but it requires a tremendous amount of trust from all stakeholders. ...
” BioIntelliSense’s medical-grade BioButton® wearable device, along with its algorithmic-based data services, enable effortless remote data capture and continuous multi-parameter monitoring on a single device in both acute and postacute settings. ...
It will conduct multiple trial emulations in various data sources, beginning with a one-year focus on oncology. Using the Aetion Evidence Platform, the Initiative will help identify when and how RWE can support the goals of advancing efficient access to medication and improving patient care. “xCures has implemented real-time access to retrospective and ...
ByxCures
You will no longer have to wait for days for a central diagnostic laboratory to provide critical medical test data regarding your health. This program showcases a range of young diagnostic companies that are poised to launch exciting products and services that will truly change your ...
Medical robotics innovator Noah Medical provided physicians attending the American College of Chest Physicians 2022 meeting with a preview of study data documenting its high tool in lesion rate. ...
By integrating xCures’ rich real-world longitudinal clinical data with mProbe’s cancer proteomics panels, the two companies are working to expedite the discovery of predictive, diagnostic, and prognostic biomarkers for cancer. ...
ByxCures
Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company focused on developing products to treat and transform the lives of patients suffering from venous and other diseases, announced positive outcomes of the fully enrolled 800-patient FLASH registry in pulmonary embolism (“PE”). The data was presented during ...
The most common adverse events associated with zuranolone included headache, somnolence, dizziness and sedation. Data from a post-hoc analysis of 4 studies in the LANDSCAPE program demonstrated that improvements in depressive symptoms with zuranolone at Day 15 were sustained beyond the end of treatment. ...
Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company focused on developing products to treat and transform the lives of patients suffering from venous and other diseases, announced three new data sets will be presented during Late-Breaking Clinical Trial sessions at the 2022 TCT (Transcatheter Cardiovascular ...
With the number of medical research papers published daily, we know it’s challenging to stay up-to-date. We strongly believe that the way medical scientific data reaches professionals needs a change: quick, transparent, and available wherever you are. ...
“For us, as a full voting member of T1DC, this is not only an important opportunity to be at the forefront of a changing regulatory landscape, but our contribution of data from previous trials also underlines the robustness of the evidence underpinning the safety and efficacy of our diabetes vaccine,” said Ulf Hannelius, President and CEO of Diamyd ...
Initial results show the duodenal jejunal bypass liner (DJBL) technology met overall glycemic control efficacy and SAE related device removal safety endpoints Findings Presented at DDW 2022 BOSTON – June 15, 2022 – GI Dynamics, a medical device company that is developing the EndoBarrier® System for patients diagnosed with type 2 diabetes and obesity, announced ...
PISA, Italy, May 26,2022 - Medical Microinstruments (MMI) SpA. a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced the launch of its Symani Surgical System Simulator developed by VirtaMed. ...
Key data highlights with the Evoke® System to include holistic composite treatment outcomes for disrupting the chronic pain cycle; opioid-sparing effects of therapy; real-world results; and cost-effectiveness compared to open-loop stimulation. Saluda Medical Pty Limited (“Saluda Medical”), a global medical device ...
How much do you know about the development of your favorite products? What about the devices you encounter at your doctor’s office? So much of the work that goes into every single thing we use remains unseen by the user or consumer, from concept development to design to ...
Honorary professor Lee Man-Yeong was appointed as CMO and head of the data center for medical advice and data center establishment. He’s a professor of Circulatory Internal Medicine and an authority in the field of arrhythmia, who continued research and treatment of arrhythmia during his tenure. ...
(Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced positive results of an observational, cohort study using real-world evidence (RWE) data from adult patients with chronic rhinosinusitis (CRS) with or without nasal polyps who underwent endoscopic sinus surgery (ESS). ...